About
NovaScan develops MarginScan™, a compact device using spectral bioimpedance and AI/ML to detect and localize cancer at surgical margins in real-time, enabling more precise surgeries without interfering with standard histopathology.
Explore NovaScan's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.